The @HOME project aims to enhance patient welfare and quality of life across the EU. The project introduces next-generation, user-friendly, cost-effective and interoperable general-interest health services by ensuring hospitals make best use of state of the art technology in communications (UMTS, Bluetooth, data privacy and secure connections) and ubiquitous medical sensors. The @HOME system is primarily addressed to European hospitals and their patients. It is envisaged as a post-stationary application, i.e. it will come into play once the patient has received hospital treatment and is recovering. During the recovery phase, the patient is often hospitalised in order to monitor critical, but often simple to measure, parameters, such as temperature, blood pressure, pulse rate etc. Another parameter which is of interest and which will be investigated is treatment compliance. The objective of the project is to equip clinics with state of the art infrastructure, which will allow for continuity in patient treatment at home and, often, a faster dispatch of patients. By the end of the project, the @HOME platform will enable hospitals to perform remote regular and reliable health monitoring of patients residing and recovering at their homes and will promptly advise the clinic staff in case of an emergency. Reciprocally, @HOME will provide information services regarding the recovery of the patients to the patients themselves and their carers/ relatives. Finally, the system will be validated via clinical trials on two pilot projects.
The @HOME project will produce a robust platform for real-time remote monitoring of patients at their home by their doctors at the hospital. @HOME will be addressed to two patient groups and their doctors: patients recovering after hospital treatment and chronically ill patients. The @HOME system will be evaluated within two pilot applications: Post-surgery Pilot and Psychiatry Pilot. The objectives of the @HOME application are highlighted below:
.Lower relapse rate for chronically ill patients. Monitoring of treatment compliance will enable the doctors to intervene when chronically ill patients do not conform. This rate currently stands at the very high fraction of 60%. @HOME expects to reduce this to 40%.
.Shorter hospitalisation period for patients. Physically ill patients treated in a hospital will be able to return home sooner. Their doctors will be able to monitor their progress remotely in real time by using the @HOME infrastructure. The period of hospitalisation may be reduced by as much as 30%.
.Lower cost for patient treatment. This is true for both chronic disorders and post-surgery cases. Cost reduction will be of the order of 10%-20%.
.Quality of life for the patient. @HOME will be a high-tech application in the service of citizens. Its use will result to less frequent/ shorter hospitalisations of patients.
.Health Information for the patient. @HOME will feature an Internet-based service where patients and their carers will be able to monitor their progress and obtain useful advice and information for their recovery.
.Increased capacity and income for hospitals. A hospital that makes good use of @HOME has the potential to treat more patients. A patient dispatched earlier leaves an empty bed, which can be occupied by another patient. It is estimated that hospitals may treat as many as 10% more patients per year without investment on new buildings.
The @HOME consortium proposes the following plan:
.Project Management will last through the whole of the project. The co-ordinator is responsible for this task (WP1).
.The @HOME consortium proposes an initial 4-month phase where the user requirements will be drawn out (WP2). WP1 is completed in Project Month (PM) 4 with the definition of the reference architecture. The Quality Assurance Plan for the project will be prepared by the end of PM3.
.Following the definition of User Requirements and Reference Architecture, the project will proceed with the System Specification and Design (WP3), which will be ready by the end of PM7.
.System Development follows (WP4), where all components will be concurrently materialised with the aim to produce the early module prototypes by PM13. The integration of these modules to a complete early prototype of the @HOME system will take place by the end of PM16.
.Early Prototype Testing and Evaluation (WP6) will begin on PM16 up till PM20. At the same time preparations for medical tests, based on proper medical protocols will begin. These clinical tests will last until the end of the project, i.e. PM27. Their aim is to scientifically prove the benefits of the @HOME system.
.Refinements and Integration of the final prototype (WP5) will be based on the feedback acquired by the testing and evaluation phase (from WP6). WP5 will begin on PM18 and will be completed on PM22, in time for the medical tests mentioned above.
.Dissemination and Exploitation work will take place all through the project (WP7). Similarly, effort will be allocated to Assessment and Validation (WP8) of the project as a whole, in order to ensure that @HOME is on track and will succeed in reaching its targets.
1. System Requirements
2. Overall Architecture
3. Full specification of early prototypes
4. Early prototypes of all modules
5. Final prototype
6. First prototype evaluation
7. Final prototype evaluation
8. Clinical tests results
Funding SchemeCSC - Cost-sharing contracts
N20 9BH London